# Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Organization · id `maternal:nichd` · Maternal & Newborn Atlas · release `c7fb95f1d15a7d13` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: NICHD

Browse, life stage: Pregnancy; Newborn  
Browse, care area: Pregnancy conditions; The baby before birth; Labour and birth; Breastfeeding and lactation; The baby's first year  

## In plain language

A research institute of the US National Institutes of Health that works on child health, pregnancy and development. It is listed as a funder of the NICHD Fetal Growth Studies and the Stillbirth Collaborative Research Network.

## Technical summary

ROR record 04byxyr05 (facility, funder; parent National Institutes of Health). NICHD says its Neonatal Research Network began in 1986 under the institute's Pregnancy and Perinatology Branch and links neonatal intensive care units across the United States. Funding for the two studies comes from the PubMed grant lists (agency NICHD NIH HHS). Other roles of NICHD are not recorded here because the sources read do not state them.

## Connected pages

- Both are institutes of the US National Institutes of Health: National Heart, Lung, and Blood Institute (NHLBI) (`maternal:nhlbi`)
- Includes: NICHD Neonatal Research Network (`maternal:nichd-nrn`)
- Related to: NICHD Safe to Sleep campaign (`maternal:safe-to-sleep-campaign`)
- Funds: ARRIVE trial (induction at 39 weeks in low-risk first births) (`maternal:arrive-trial`)
- Funds: MFMU trial of treatment for mild gestational diabetes (`maternal:mfmu-mild-gdm-trial`)
- Funds: NICHD Fetal Growth Studies (`maternal:nichd-fetal-growth-studies`)
- Sponsors: PROBIT trial (Promotion of Breastfeeding Intervention Trial) (`maternal:probit-trial`)
- Funds: Stillbirth Collaborative Research Network causes-of-death study (`maternal:scrn-causes-of-stillbirth`)

## Provenance

Content hash: 540fed23a4058283ecf10a20afe63152d67159a7da6059f204304fa0ef360756
Last substantive edit: 2026-10-14
Evidence last checked: 2026-10-14